:: Altroz - News Magazine HTML Template ::

Language:

weight loss drug News

Eli Lilly's Weight-Loss Drug Breakthrough Sparks 13% Stock Surge in Premarket Trading

Sarah Mitchell 17 Apr, 2025

Eli Lilly and Co. shares surged over 13% in premarket trading following the announcement of positive phase 3 results for its ACHIEVE-1 weight loss drug, marking a significant miles...

Business

Novo Nordisk Faces Significant Stock Drop Following Obesity Drug Trial Disappointment

Emily Rodriguez 20 Dec, 2024

Novo Nordisk's stock dropped 18% after a phase three trial for its CagriSema weight loss drug yielded results below expectations. The drug, combining semaglutide and Cagrilintide, ...